2 unknown, 1 completed. 2 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Jun Liu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early Warning Score Combined With Bedside Assessments: Accelerating Emergency Care To Improve Prognosis Optimized ED Bedside Nursing Protocol - Acute Critical Illnesses in Emergency Settings, Process Optimization of Early Warning &Amp; Assessment for At-risk Emergency Patients | Not applicable | Completed | Jun Liu | 1000 | 2024-05-01 | 2025-11-25 |
| A Single-arm Exploratory Study of Neoadjuvant Therapy Tislelizumab, pemetrexed, cis-platemum - Lung Adenocarcinoma | Not applicable | Unknown | Jun Liu | 28 | 2022-08-01 | 2023-06-08 |
| The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis Fecal Microbiota Transplantation - Ulcerative Colitis, Fecal Microbiota Transplantation | Phase 2 / Phase 3 | Unknown | Jun Liu | 20 | 2015-05-01 | 2015-05-06 |
Adenocarcinoma of Lung (1) · Colitis, Ulcerative (1)
Carboplatin (1) · Fecal Microbiota Transplantation (1) · Pemetrexed (1) · tislelizumab (1)
China (2)
PMID 27649072, PMID 28993097, PMID 35962454, PMID 36625695, PMID 36951452, PMID 37331563